Caitlin Ciavarro

Caitlin Ciavarro has a diverse and extensive work experience in the medical research and pharmaceutical industry. Caitlin started their career as a Research Associate at Newark Beth Israel Medical Center in 2002. In 2003, they joined Novartis Vaccines and Diagnostics and held several positions, including Clinical Research Associate, Senior Clinical Research Associate, Clinical Trial Manager, Senior Clinical Trial Manager, and Associate Director - Senior Global Trial Manager. Caitlin then moved to GSK in 2015, where they worked as an Associate Director - Senior Global Trial Manager. In 2016, they joined Sanofi Genzyme as the Director - Project Lead, MS and Rare Diseases. Currently, they are the Head of Clinical Operations at the Bill & Melinda Gates Medical Research Institute, a role they have held since September 2021.

Caitlin Ciavarro holds a Master of Business Administration (MBA) degree in Global Management, which they obtained from the Boston College - Carroll School of Management from 2012 to 2014. Prior to that, they completed their Bachelor of Arts (B.A) degree in Political Science at Rutgers University from 1998 to 2002. Furthermore, they have a certification in Project Management Professional (PMP) from PMI, although the specific month and year of obtaining this certification are not provided.